Advertisement

Skeletal Radiology

, Volume 44, Issue 3, pp 451–455 | Cite as

Gemcitabine-induced radiation recall myositis

  • Joshua Adam DelavanEmail author
  • Junzo P. Chino
  • Emily N. Vinson
Case Report

Abstract

Radiation recall is an uncommon phenomenon in which administration of a chemotherapeutic agent induces an acute inflammatory reaction in previously irradiated tissues, often weeks to years after completion of radiotherapy. This entity is well known to medical and radiation oncologists, however only three cases have been reported in radiology journals. We present a case of gemcitabine-induced radiation recall that manifested as myositis with associated dermatitis in the posterior thigh of a patient with remote history of localized radiotherapy for biopsy-proven breast cancer metastasis. We also present a brief literature review to update the topic of radiation recall in imaging, and emphasize the importance of knowledge of this phenomenon when considering the differential diagnosis of myositis/dermatitis in a patient who has received cancer treatment.

Keywords

Radiation recall Myositis Gemcitabine 

Notes

Conflict of interest

The authors declare they have no conflicts of interest.

References

  1. 1.
    D’Angio GJ, Farber S, Maddock CL. Potentiation of X-ray effects by actinomycin D. Radiology. 1959;73:175–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Eckardt MA, Bean A, Selch MT, Federman N. A child with gemcitabine-induced severe radiation recall myositis resulting in a compartment syndrome. J Pediatr Hematol Oncol. 2013;35(2):156–61.PubMedCrossRefGoogle Scholar
  3. 3.
    Azria D, Magne N, Zouhair A, Castadot P, Culine S, Ychou M, et al. Radiation recall: a well-recognized but neglected phenomenon. Cancer Treat Rev. 2005;31(7):555–70.PubMedCrossRefGoogle Scholar
  4. 4.
    Burris 3rd HA, Hurtig J. Radiation recall with anticancer agents. Oncologist. 2010;15(11):1227–37.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59(3):237–45.PubMedCrossRefGoogle Scholar
  6. 6.
    Boal DK, Newburger PE, Teele RL. Esophagitis induced by combined radiation and adriamycin. AJR Am J Roentgenol. 1979;132(4):567–70.PubMedCrossRefGoogle Scholar
  7. 7.
    Ma LD, Taylor GA, Wharam MD, Wiley JM. "Recall" pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology. 1993;187(2):465–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Garza LA, Yoo EK, Junkins-Hopkins JM, VanVoorhees AS. Photo recall effect in association with cefazolin. Cutis. 2004;73(1):79–80. 5.PubMedGoogle Scholar
  9. 9.
    Extermann M, Vogt N, Forni M, Dayer P. Radiation recall in a patient with breast cancer treated for tuberculosis. Eur J Clin Pharmacol. 1995;48(1):77–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Parry BR. Radiation recall induced by tamoxifen. Lancet. 1992;340(8810):49.PubMedCrossRefGoogle Scholar
  11. 11.
    Bostrom A, Sjolin-Forsberg G, Wilking N, Bergh J. Radiation recall–another call with tamoxifen. Acta Oncol. 1999;38(7):955–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Singer EA, Warren RD, Pennanen MF, Collins BT, Hayes DF. Tamoxifen-induced radiation recall dermatitis. Breast J. 2004;10(2):170–1.PubMedCrossRefGoogle Scholar
  13. 13.
    Abadir R, Liebmann J. Radiation reaction recall following simvastatin therapy: a new observation. Clin Oncol (R Coll Radiol). 1995;7(5):325–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Del Guidice SM, Gerstley JK. Sunlight-induced radiation recall. Int J Dermatol. 1988;27(6):415–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Welsh JS, Torre TG, DeWeese TL, O’Reilly S. Radiation myositis. Ann Oncol. 1999;10(9):1105–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Burdon J, Bell R, Sullivan J, Henderson M. Adriamycin-induced recall phenomenon 15 years after radiotherapy. JAMA. 1978;239(10):931.PubMedCrossRefGoogle Scholar
  17. 17.
    Barlesi F, Tummino C, Tasei AM, Astoul P. Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis. Lung Cancer. 2006;54(3):423–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner J, Kemeny N. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer. 2004;100(9):1793–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Pentsova E, Liu A, Rosenblum M, O’Reilly E, Chen X, Hormigo A. Gemcitabine-induced myositis in patients with pancreatic cancer: case reports and topic review. J Neurooncol. 2012;106(1):15–21.PubMedCrossRefGoogle Scholar
  20. 20.
    Saif MW, Sellers S, Russo S. Gemcitabine-related radiation recall in a patient with pancreatic cancer. Anticancer Drugs. 2006;17(1):107–11.PubMedCrossRefGoogle Scholar
  21. 21.
    Jeter MD, Janne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002;53(2):394–400.PubMedCrossRefGoogle Scholar

Copyright information

© ISS 2014

Authors and Affiliations

  • Joshua Adam Delavan
    • 1
    Email author
  • Junzo P. Chino
    • 2
  • Emily N. Vinson
    • 1
  1. 1.Department of RadiologyDuke University Medical CenterDurhamUSA
  2. 2.Department of Radiation OncologyDuke University Medical CenterDurhamUSA

Personalised recommendations